ArticleScientific reports2025
Nonlinear dose-response relationship between red blood cell distribution width to platelet ratio and 90-day unfavorable outcomes in acute ischemic stroke: a prospective cohort study.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association of MTHFR and platelet-related blood cell ratio parameters with ischemic stroke in Gansu population.BMC cardiovascular disorders · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Currently, there is relatively limited research regarding the relationship between the red blood cell distribution width to platelet ratio (RPR) and the prognosis of patients with acute ischemic stroke (AIS). Therefore, this study aims to investigate the association between RPR and the incidence of unfavorable functional outcomes in AIS patients. This study utilized a prospective cohort design and included 1,682 patients who had been diagnosed with AIS and were treated at Shenzhen Second People's Hospital from January 2022 to June 2024. To evaluate the relationship between RPR and the incidence of 90-day unfavorable outcomes, a binary logistic regression model was employed. Furthermore, an additional logistic regression model that included cubic spline functions was utilized to investigate possible nonlinear associations between them. A range of sensitivity analyses and subgroup analyses were conducted to strengthen the reliability of the results. After adjusting for confounding variables, the binary logistic regression analysis demonstrated that for each 0.1 unit increase in RPR, the incidence of unfavorable outcomes at 90 days for AIS patients increased by 45.5% (OR = 1.455, 95% CI: 1.268-1.669). Additionally, the study found a nonlinear relationship between RPR and 90-day unfavorable outcomes, with an inflection point occurring at RPR = 0.33. On the left side of the inflection point, the OR for the relationship between RPR (per 0.1 unit) and 90-day unfavorable outcomes was 1.708 (95% CI: 1.403-2.080). On the right side of the inflection point, the OR for their relationship was 0.942 (95% CI: 0.630-1.410). Sensitivity analysis further confirmed the reliability of these results. This study identifies a distinct positive link between RPR and 90-day unfavorable outcomes in patients with AIS. Additionally, a non-linear relationship was observed in the relationship between them. Specifically, when the RPR value falls below 0.33, a significant positive association is noted. These findings offer valuable insights for improving rehabilitation strategies and enhancing clinical management for AIS patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.